Vascular Grafts Market Report 2025

The vascular grafts market size has grown steadily in recent years. It will grow from $3.25 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 4%. The growth in the historic period can be attributed to increase in cardiovascular diseases (CVDs), increased geriatric population, strong economic growth in emerging markets, rise in healthcare expenditure and growth in the number of healthcare facilities.

The vascular grafts market size is expected to see steady growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing number of renal diseases, increase in hypertension prevalence, sedentary lifestyles, rapid growth in the geriatric population, increase in diabetes, increase in cardiovascular diseases (CVDs) and rise in healthcare expenditure. Major trends in the forecast period include investing in the latest technology for improving the compliance with smaller vascular grafts, investing in technology such as 3D cell printing, for greater safety and ultimately higher success rates, investing in cell-free vascular grafts, investing in monitoring technology such as smart patches or self-monitoring devices and investing in research and development for newer and more innovative solutions to improve patient care.

The global vascular grafts market is experiencing growth, driven by the increasing prevalence of vascular diseases. A study by the National Center for Biotechnology Information in the US reveals that cardiovascular diseases are the leading cause of death worldwide. The American Heart Association (AHA) reports approximately 7.9 million myocardial infarctions annually in the US. The high incidence of vascular diseases, such as coronary artery disease, has led to around 20,000 coronary bypass grafts in England each year. This trend is expected to fuel the demand for vascular grafts globally.

The growth of the vascular grafts market is anticipated to be driven by the increasing geriatric population. The term geriatric population refers to a demographic trend where the proportion of older individuals in a population rises due to lower fertility rates and longer life expectancy. As people age, they are more susceptible to vascular disorders, and vascular grafts play a critical role in treating these conditions, such as aortic dissection, by repairing damaged aortas and restoring blood flow. Aortic dissection is a severe condition where a tear in the inner aorta layer allows blood to flow between the aortic wall layers. For example, in October 2022, the World Health Organization (WHO) reported that one in six individuals worldwide will be 60 or older by 2030, with this population expected to reach 2.1 billion by 2050. Consequently, the aging population is significantly contributing to the growth of the vascular grafts market.

Companies in the vascular grafts market are actively investing in technological advancements to develop innovative products, including customizable vascular grafts. Terumo Aortic's recent launch of RelayPro, a thoracic stent graft system, exemplifies this trend. This low-profile device caters to patients with smaller access vessels undergoing thoracic endovascular aortic repair (TEVAR). The customizable features, such as diameters, lengths, tapers, and proximal configurations, provide physicians with options tailored to individual patient anatomies.

Leading companies in the vascular grafts market are prioritizing the development of innovative products to strengthen their market position. These innovations encompass new and advanced technologies designed to effectively treat vascular disorders, offering reliable and durable conduits for blood flow that address the limitations of conventional grafts. For example, in January 2023, Viz.ai, a U.S.-based medical technology company specializing in AI-powered software, launched the AI-Powered Viz Vascular Suite. This platform uses artificial intelligence to automatically analyze various imaging modalities, such as CT scans and ECGs, to detect potential vascular diseases. Upon identifying a pathology, the app instantly alerts providers and displays high-quality patient scans on their mobile devices. Clinicians can use Viz Vascular Suite to coordinate care for vascular pathologies within a hospital network and facilitate secure, HIPAA-compliant communication between specialists. Enhanced by AI, the platform enables immediate team activation, promoting informed and efficient treatment decisions.

In August 2022, Gore & Associates, a US-based materials science company, acquired InnAVasc Medical Inc., a US-based manufacturer of vascular grafts for hemodialysis. This strategic move is anticipated to enhance patient outcomes and improve dialysis treatment for individuals with end-stage renal disease, highlighting the industry's commitment to continuous advancement.

Major companies operating in the vascular grafts market include B. Braun Melsungen AG, Abbott Laboratories, Becton Dickinson and Company, Cardinal Health Inc., W. L. Gore & Associates Inc., Terumo Medical Corporation, Medtronic Plc, Getinge, Endologix, Cook Medical, MicroPort, CR Bard, Biovic, Creganna, Novomed Incorporation Private Limited, Marizyme Inc., Gore Medical, LeMaitre Vascular, Olympus Medical Systems Corporation, Japan Lifeline, JOTEC, Vascutek, RUA Life Sciences, Vascular Flow Technologies, Bolton Medical, Kips Bay Medical Incorporated, Cryolife, Vascular Graft Solutions Ltd.

North America was the largest region in the vascular grafts market in 2024. Western Europe was the second largest region in the vascular grafts market report. The regions covered in the vascular grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Vascular grafts find application in repairing diseased or obstructed blood vessels through a surgical procedure known as vascular grafting or vascular bypass. The purpose of vascular grafting is to circumvent either partial or complete blockages in arteries by reconnecting blood vessels, thereby enhancing blood flow through the redirection of blood from one body area to another.

The primary products within the vascular grafts market include hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery bypass grafts. The term 'endovascular stent graft' denotes a minimally invasive approach employed for treating aortic aneurysms, used to assess the presence of abdominal pain, disease symptoms, and the size of the aneurysm. Raw materials utilized encompass polyester grafts, ePTFE, polyurethane grafts, and biosynthetic grafts. Vascular grafts serve various applications such as coronary artery disease, aneurysms, vascular occlusion, and renal failure, with hospitals and ambulatory surgical centers being the primary end-users.

The vascular grafts market research report is one of a series of new reports that provides vascular grafts market statistics, including vascular grafts industry global market size, regional shares, competitors with a vascular grafts market share, detailed vascular grafts market segments, market trends and opportunities, and any further data you may need to thrive in the vascular grafts industry. This vascular grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular grafts market consists of sales of polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.